Viewing Study NCT02201992


Ignite Creation Date: 2025-12-24 @ 3:32 PM
Ignite Modification Date: 2026-02-02 @ 1:07 PM
Study NCT ID: NCT02201992
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-19
First Post: 2014-07-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Sponsor: ECOG-ACRIN Cancer Research Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module